Form 4: Director Eric Shuey Sells 243K LifeStance Health Shares
Statement of Changes in Beneficial Ownership
Director Eric Shuey reported the sale of 243,362 shares of LifeStance Health Group, Inc. common stock at an average price of $8.02.
Summary
- Director Eric Shuey disposed of 243,362 shares of common stock on May 12, 2026.
- The shares were sold at a price of $8.02 per share.
- The transaction was executed through the Eric Shuey Gift Trust.
- Following the transaction, the reporting person maintains a beneficial interest in 867,562 shares held by the trust and 93,982 shares held directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as it reflects a routine insider transaction rather than a material change in corporate strategy or financial health.
Positives
- The transaction represents a standard divestment by an insider rather than a fundamental change in company operations.
Negatives
- Significant insider selling can sometimes be perceived by the market as a lack of confidence in near-term share price appreciation.
Risks
- Market volatility associated with large block sales of equity by company insiders.
Future Outlook
No forward-looking guidance or strategic outlook was provided in this regulatory filing.
Industry Context
StockSavvy.ai notes that insider selling is common among healthcare service providers and does not necessarily indicate a change in the company's underlying business performance or strategic direction.
Comparison to Industry Standards
- Insider sales of this magnitude are typical for directors and executives managing personal wealth or trust distributions in the healthcare sector.
- The transaction volume is consistent with standard liquidity events for board members of mid-cap healthcare companies.
Related Party Transactions
- The shares were held by the Eric Shuey Gift Trust, for which the reporting person disclaims beneficial ownership except to the extent of his pecuniary interest.
Stakeholder Impact
- Shareholders should monitor for potential short-term price volatility following the disclosure of a large insider sale.
Next Steps
- No future actions or milestones were disclosed in this filing.
Key Dates
| Date | Description |
|---|---|
| 05/12/2026 | Date of the reported stock sale transaction. |
| 05/14/2026 | Date the Form 4 was signed and filed with the SEC. |
Keywords
LifeStance Health, LFST, Insider Trading, Form 4, Director Sale, Equity Divestment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.